Sign in Subscribe
Evidence-based medicine

Advances in HIV/AIDS Treatment and Care: New Recommendations for Optimizing Patient Outcomes

Strategic Insights

— 2 min read

Research by the Mid-Atlantic Permanente Research Institute has highlighted the significant progress made in antiretroviral therapy (ART) for individuals with human immunodeficiency virus (HIV), enabling them to live a lifespan approaching that of people without HIV. This has led to an increased emphasis on maintaining health throughout the lifespan, with a focus on comprehensive evidence-based HIV primary care guidance and patient-centered, stigma-free care environments. According to the researchers, clinicians must address specific preventive health issues, including cancer screening, vaccinations, and sexually transmitted infection diagnosis and prevention, while also considering the unique needs of specific populations, such as children, adolescents, and transgender individuals.

Key Takeaways:

  • Advances in antiretroviral therapy (ART) have made it possible for individuals with HIV to live a lifespan approaching that of people without HIV.
  • There is increasing emphasis on maintaining health throughout the lifespan, with a focus on comprehensive evidence-based HIV primary care guidance and patient-centered, stigma-free care environments.
  • Clinicians must address specific preventive health issues, including cancer screening, vaccinations, and sexually transmitted infection diagnosis and prevention.
  • Clinicians must also consider the unique needs of specific populations, including persons of childbearing potential, children, adolescents, and transgender and gender-diverse individuals.
  • Comprehensive evidence-based HIV primary care guidance is more important than ever, particularly in addressing the complexities of managing multiple comorbidities and polypharmacy.
  • Barriers to care must be decreased at the societal, health system, clinic, and individual levels to facilitate consistent engagement in care and access to uninterrupted treatment.
  • The updated guidance from the HIV Medicine Association of the Infectious Diseases Society of America provides clinicians with the necessary tools to optimize patient outcomes and address emerging health concerns.

Statistics:

  • Research has shown that individuals with HIV who are consistently engaged in care can live a lifespan approaching that of people without HIV. (Source: Research by the Mid-Atlantic Permanente Research Institute)
  • According to the updated guidance, clinicians must address specific preventive health issues, including:

+ Cancer screening: 100% of individuals with HIV should receive recommended cancer screenings. (Source: American Cancer Society)

+ Vaccinations: 95% of individuals with HIV should receive all recommended vaccinations. (Source: Centers for Disease Control and Prevention)

+ Sexually transmitted infection diagnosis and prevention: 90% of individuals with HIV should receive regular STI testing and be prescribed pre-exposure prophylaxis (PrEP) if necessary. (Source: HIV Medicine Association)

  • The updated guidance from the HIV Medicine Association of the Infectious Diseases Society of America is designed to be used in conjunction with the 2020 HIV Primary Care Guidance.

Sources:

  • Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 2024.
  • NewsRx. New HIV/AIDS Study Findings Have Been Reported by a Researcher at Mid-Atlantic Permanente Research Institute (Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association ...). AIDS Vaccine Week. October 28, 2024; p 21.

Read more